Search 33,000+ CME courses
Back

PRIME Education, Inc. (PRIME®)

  • Breast Neoplasms
  • Treatment Adherence and Compliance

A Proactive Approach to Managing Adverse Events Associated With CDK4/6 Inhibitors

Adverse events can compromise treatment adherence and outcomes in HR+/HER2- early-stage breast cancer. This case-based activity focuses on early recognition, monitoring, and management strategies to address CDK4/6 inhibitor toxicities. Gain practical insights on communication and collaboration that enable proactive care and keep patients on track with therapy. In this interactive Clinical Case Challenge, you will: Listen to a patient’s real-world experience with toxicity management Identify and monitor common toxicities associated with CDK4/6 inhibitors Apply practical approaches for timely management of adverse events Enhance collaborative care to support treatment adherence and outcomes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.25 creditsAAPA Category 1 Credit™Up to 0.25 creditsAMA PRA Category 1 Credit™Up to 0.25 creditsNursingUp to 0.25 creditsPharmacyUp to 0.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Free

Reported to ACCME by the provider

  • Case study / clinical scenario
  • Credit · Up to 0.25 credits
  • Commercial Support
  • Released
    Oct 31, 2025
  • Last day to claim credit
    Oct 31, 2026 3 weeks left

Related courses

See all

Other providers’ courses on the same topic

More from PRIME Education, Inc. (PRIME®)

See all

This provider’s courses closest to this one